RET and non-small cell lung carcinoma: The others, phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha (PI3KCA), v-RAF murine sarcoma viral oncogene homolog B1 (BRAF), Proto-oncogene tyrosine-protein kinase (ROS1), rearrangements during transfection (RET) collectively account for 1–4% NSCLC manifestations [4, 5].